S. Hirokawa

Reduction therapy of alanine aminotransferase levels prevent HCC development in patients with HCV-associated cirrhosis.

Y. Rino, N. Yukawa, S. Ohkawa, 2006, Anticancer research.

Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.

Katsuaki Tanaka, S. Ohkawa, S. Fujiyama, 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Sustained Low Alanine Aminotransferase Levels Can Predict the Survival for 10 Years without Hepatocellular Carcinoma Development in Patients with Hepatitis C Virus-Associated Liver Cirrhosis of Child Stage A

Katsuaki Tanaka, Y. Rino, N. Okamoto, 2004, Intervirology.

Serum alanine aminotransferase levels and survival after hepatectomy in patients with hepatocellular carcinoma and hepatitis C virus‐associated liver cirrhosis

Y. Kameda, A. Kakita, Y. Rino, 2003, Cancer science.

Risk Factors for the Progression of Endoscopic Barrett’s Epithelium in Japan: A Multivariate Analysis Based on the Prague C & M Criteria

Hirokazu Takahashi, H. Kirikoshi, A. Nakajima, 2009, Digestive Diseases and Sciences.

Allergic reactions to oxaliplatin in a single institute in Japan.

T. Ishikawa, T. Chishima, Y. Ichikawa, 2009, Japanese journal of clinical oncology.

Clinical characteristics of patients with gastric perforation following endoscopic submucosal resection for gastric cancer.

Hirokazu Takahashi, H. Kirikoshi, A. Nakajima, 2009, Hepato-Gastroenterology.

A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer.

H. Ueno, J. Furuse, M. Ikeda, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.